Article Details
Retrieved on: 2022-06-07 17:24:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
For the remdesivir trial, investigators assigned 8275 patients (1:1) to receive remdesivir (n=4146, 10 daily infusions) or a control drug (n=4129).
Article found on: www.infectiousdiseaseadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here